Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Temporal and spatial regulation of gene expression during endospore formation in Bacillus subtilis prompted us to investigate the molecular mechanisms that coordinate the phosphorelay. We targeted KinA for random mutagenesis. In addition, we constructed KinA-GFP transcriptional fusions for verification, via fluorescence. Four distinct types of sporulation-defective mutants were identified as inactive (no sporulation), hypoactive (low sporulation efficiency), isoactive (same efficiency as wild-type), and hyperactive (high efficiency) mutants. Surprisingly, the
beta-galactosidase
activity of hyperactive mutants was barely greater than that of the wild-type strain; the only noticeable difference was early synthesis of KinA, which could allow them to activate Spo0A precociously, undergo sporulation earlier, and yield more spores. There was no fluorescence emission by the spore-defective mutant, which confirmed the presence of a truncated KinA (nonsense mutation) in inactive strains; other mutants harbored missense or silent mutations. We determined the nucleotide sequences of KinA mutants and found a conserved C-terminus region; more variability was observed in the N-terminus region, involving the
PAS
-A and
PAS-C
domains. We speculate that
PAS
-A, notwithstanding its ATPase activity, has only a minor role in KinA activity, whereas
PAS
-B was found to be indispensable. Our results emphasize the importance of temporal coordination of gene expression during the sporulation process and corroborate the necessity of Spo0A phosphorylation by KinA, which stimulates SpoIIG expression. We further propose a novel hypothetical model that purposely dubbed the "C-shaped intertwined model", which requires both homodimerization and spatial proximity between
PAS
-A and histidine H(405) of two different KinA molecules.
...
PMID:Genetic and biochemical analyses of sensor kinase A in Bacillus subtilis sporulation. 2196 64
PAS
kinase 1 (Psk1) is a key regulator of respiration in
Saccharomyces cerevisiae
Herein the molecular mechanisms of this regulation are explored through the characterization of its substrate, Centromere binding factor 1 (Cbf1).
CBF1
-deficient yeast displayed a significant decrease in cellular respiration, while
PAS
kinase-deficient yeast, or yeast harboring a Cbf1 phosphosite mutant (T211A) displayed a significant increase. Transmission electron micrographs showed an increased number of mitochondria in
PAS
kinase-deficient yeast consistent with the increase in respiration. Although the
CBF1
-deficient yeast did not appear to have an altered number of mitochondria, a mitochondrial proteomics study revealed significant differences in the mitochondrial composition of
CBF1
-deficient yeast including altered Atp3 levels, a subunit of the mitochondrial F
1
-ATP synthase complex. Both
beta-galactosidase
reporter assays and western blot analysis confirmed direct transcriptional control of
ATP3
by Cbf1 In addition, we confirmed the regulation of yeast lipid genes
LAC1
and
LAG1
by Cbf1 The human homolog of Cbf1, Upstream transcription factor 1 (USF1), is also known to be involved in lipid biogenesis. Herein, we provide the first evidence for a role of USF1 in respiration since it appeared to complement Cbf1
in vivo
as determined by respiration phenotypes. In addition, we confirmed USF1 as a substrate of human
PAS
kinase (hPASK)
in vitro
Combined, our data supports a model in which Cbf1/USF1 functions to partition glucose toward respiration and away from lipid biogenesis, while
PAS
kinase inhibits respiration in part through the inhibition of Cbf1/USF1.
...
PMID:The Regulation of Cbf1 by PAS Kinase Is a Pivotal Control Point for Lipogenesis
vs.
Respiration in
Saccharomyces cerevisiae
. 3038 Dec 92
<< Previous
1
2